The Year in Unfair Competition and Trade Secrets: 2023 Developments and What Is on the Horizon for 2024

The Year in Unfair Competition and Trade Secrets: 2023 Developments and What Is on the Horizon for 2024

Federal agencies are ramping up efforts to regulate and restrict the use of restrictive covenant agreements in employment. Three states passed laws in 2023 that ban or severely curtail the use of... Read more »
Supreme Court Appears Ready to Hold Title VII Does Not Require a Materially Adverse Employment Action – Significant Implications for Employers on the Horizon

Supreme Court Appears Ready to Hold Title VII Does Not Require a Materially Adverse Employment Action – Significant Implications for Employers on the Horizon

On December 6, 2023, the Supreme Court of the United States (SCOTUS) heard arguments in Muldrow v. City of St. Louis, Missouri—a potentially pivotal case concerning whether Title VII requires plaintiffs to... Read more »
Modified Privacy Regulations May be on the Horizon

Modified Privacy Regulations May be on the Horizon

Topics: Privacy On Friday, December 8, 2024, the California Privacy Protection Agency (Agency) will meet to discuss important items, including drafting proposed regulations for employers. While the Agency has not yet commenced... Read more »

Opinion: Navigating Oregon’s New Equal Pay Horizon

Christine Sargent helps employers prepare for Oregon’s new Equal Pay rules. Portland Business Journal View (Subscription required.) Source link Reach Out Don’t hesitate to reach out to us to discuss your specific... Read more »

Is Heat Illness Regulation on the Horizon?

As heat records continue to be broken around the country, mine operators are having to direct more time and attention to protecting their personnel from the dangers of heat stress. Source link... Read more »
Amgen, FTC Settlement Allows B Horizon Acquisition to Move Forward

Amgen, FTC Settlement Allows $28B Horizon Acquisition to Move Forward

Amgen’s $28 billion purchase of Horizon Therapeutics can now proceed following a settlement with the Federal Trade Commission, but with safeguards designed to preserve competition in two rare diseases where Horizon’s drugs... Read more »
Home Privacy Policy Terms Of Use Anti Spam Policy Contact Us Affiliate Disclosure DMCA Earnings Disclaimer